Thomas D. Carey
CIK 1574633 · last filed 2026-03-02
Thomas D. Carey is a corporate insider who has filed 24 SEC Form 4 insider transactions across 3 companies since 2013. The most recent filing shows the insider was granted $60.0K of LAB on Mar 2, 2026. Across all open-market trades the lifetime net is −$7.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $217.8K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$217.8K
3
24
-$7.06M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LAB | Director | 245,340 | $0.89 | $217.8K | $0 | 5 | 2026-03-02 |
| SomaLogic, Inc. (SLGCW) Delisted | Director | — | $0.09 | — | $0 | 1 | 2023-06-12 |
| EXACT SCIENCES CORP (EXAS) Delisted | Director | 5,292 | $104.91 | $555.2K | -$7.06M | 17 | 2021-06-03 |
Recent Filings
24 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-03-02 | LAB | Grant (A) | +51,282 | $60.0K | EDGAR |
| 2025-06-24 | LAB | Grant (A) | +94,592 | $0 | EDGAR |
| 2025-03-04 | LAB | Grant (A) | +56,338 | $60.0K | EDGAR |
| 2024-07-02 | LAB | Grant (A) | +43,128 | $0 | EDGAR |
| 2024-01-09 | LAB | Grant (A) | +79,412 | $0 | EDGAR |
| 2024-01-09 | — | Disp (D) | — | $0 | |
| 2023-06-12 | SomaLogic, Inc. (SLGCW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-03 | EXACT SCIENCES CORP (EXAS) Delisted | Sell (S) | −17,000 | -$1.84M | EDGAR |
| 2020-10-23 | EXACT SCIENCES CORP (EXAS) Delisted | Grant (A) | +420 | $0 | EDGAR |
| 2020-08-04 | EXACT SCIENCES CORP (EXAS) Delisted | Mixed | −15,000 | -$2.73M | EDGAR |